✦ LIBER ✦

Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma

✍ Scribed by Joel S. Owen; Murad Melhem; Julie A. Passarell; Denise D’Andrea; Mona Darwish; Bradley Kahl

Book ID: 105993386
Publisher: Springer
Year: 2010
Tongue: English
Weight: 436 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1254-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine Produces Durable Responses

Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

✍ Bruce D. Cheson; Jonathan W. Friedberg; Brad S. Kahl; Richard H. Van der Jagt; L 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 130 KB

Pharmacokinetic profile and first prelim

Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Hsiao, Liang-Tsai; Tien, Hwei-Fang; Kuo, Ching-Yuan; Wu, Jin-Hou; Hou, Hsin-An; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Pharmacokinetic profile of Mitoguazone (

Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma

✍ Jinee Rizzo; Alexandra M. Levine; Geoff R. Weiss; Tillman Pearce; Maura Kraynak; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 697 KB

Erythropoiesis in patients with aggressi

Erythropoiesis in patients with aggressive and indolent non-Hodgkin’s lymphomas

✍ N. P. Domnikova; V. V. Degtyareva; L. M. Nepomnyashchikh 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 322 KB

Bendamustine in Patients With Rituximab-

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

✍ Friedberg, J. W.; Cohen, P.; Chen, L.; Robinson, K. S.; Forero-Torres, A.; La Ca 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 118 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB